English  |  正體中文  |  简体中文  |  Items with full text/Total items : 26999/38800
Visitors : 2401747      Online Users : 67
RC Version 4.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Adv. Search
LoginUploadHelpAboutAdminister

Please use this identifier to cite or link to this item: http://ntour.ntou.edu.tw:8080/ir/handle/987654321/43451

Title: Delivery of Grouper Interferon by Chitosan-Modified Poly(lactic-co-glycolic acid) Nanoparticles to Protect Nervous Necrosis Virus Infection
Authors: H.P. Kuo;L.L. Goh;M.W. Lu;Z. L. Kong
Contributors: 國立臺灣海洋大學:水產養殖學系
Keywords: PLGA Nanoparticles;Ultra-Sonication;Surface Modification;Drug Delivery;Interferon;Nervous Necrosis Virus
Date: 2016-07
Issue Date: 2017-08-10T06:10:55Z
Publisher: Journal of Nanoscience and Nanotechnology
Abstract: Abstract
The outbreaks of viral disease including nervous necrosis virus (NNV) have become major problems in aquaculture and cause massive mortalities of grouper larvae, leading to enormous economic losses for farms and hatcheries. Interferons (IFNs) are potent antiviral cytokines that enhance a grouper larva innate immune system by triggering various antiviral proteins. In this study, we utilized ultra-sonication to nano-encapsulate grouper IFN (gIFN) using chitosan modified poly(lactic-co-glycolic acid) (PLGA) as a carrier. Sample obtained was expressed as PLGA-gIFN NP expecting to protect IFN from the damage in a fish gastrointestinal tract. The results showed that nanoparticles (NPs) loaded with gIFN were monodisperse with sizes ranged around 150 nm and successfully achieved an acceptable encapsulation efficiency of 65.5%. Particles were stable during storage with an initial burst release in the first 4 h and shown a low cumulative release rate only of 18% which limited an anti-NNV effect of IFN in the animal test. However, with a dosage increasing from 0.05 to 0.1 μg of PLGA-gIFN/fish in oral administration, the relative percent survival (RPS) increased by 12.38 to 46.67, that seemed to be better in an increasing rate compare to the non-encapsulated one (RPS rose to 60.59 from 34.07). It is deduced that this nano-encapsulation technique could protect IFNs from damage in a fish gastrointestinal tract and performed its functionality when been uptaken into cells. Since NPs are able to approach easily using sonication, the less cytotoxic PLGA-gIFN NPs could be produced commercially as a reliable and promising aquaculture pharmaceutical product for disease prevention and treatment in fish fries.
Relation: 16(7), pp.7521-7529
URI: http://ntour.ntou.edu.tw:8080/ir/handle/987654321/43451
Appears in Collections:[水產養殖學系] 期刊論文

Files in This Item:

File Description SizeFormat
index.html0KbHTML46View/Open


All items in NTOUR are protected by copyright, with all rights reserved.

 


著作權政策宣告: 本網站之內容為國立臺灣海洋大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,請合理使用本網站之內容,以尊重著作權人之權益。
網站維護: 海大圖資處 圖書系統組
DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback